A Study of Inhaled Atropine Sulfate in Healthy Adults

Organophosphorus Poisoning Clinical Trial

Official title:
Development of an Inhaled, Dry Powder Delivery System for the Administration of Atropine Sulfate

Status Completed

Clinical Trial Summary

MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by the ADPI to atropine delivery from the AtroPen autoinjector.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00947596
Study type	Interventional
Source	MicroDose Defense Products L.L.C.
Contact
Status	Completed
Phase	Phase 1
Start date	August 2009
Completion date	August 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06111352` - Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime	Phase 2
Recruiting	`NCT06256796` - Fresh Frozen Plasma Transfusion in Acute Organophosphate Poisoning	N/A
Not yet recruiting	`NCT04393103` - Role of Intralipid in Management of Organophosphorus Poisoning	Phase 2/Phase 3